中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
20期
10-11
,共2页
周和超%陈兴贵%王镇南%余忠华
週和超%陳興貴%王鎮南%餘忠華
주화초%진흥귀%왕진남%여충화
西黄胶囊%乳腺癌%免疫功能%放疗
西黃膠囊%乳腺癌%免疫功能%放療
서황효낭%유선암%면역공능%방료
Xihuang capsules%Breast cancer%Immune function%Radiotherapy
目的:探讨西黄胶囊对乳腺癌术后放疗患者免疫功能及生活质量的影响。方法乳腺癌术后患者43例,随机分治疗组(22例)及对照组(21例)。对照组接受单纯放疗,治疗组在对照组基础上,加用西黄胶囊治疗。在治疗前及治疗后检测两组患者血清T细胞亚群水平,并比较治疗前后KPS评分。结果治疗组治疗后的CD3、CD4和CD4/CD8指标较治疗前均有提高(P<0.05),与对照组治疗后比较,差异有统计学意义(P<0.05);治疗组治疗后KPS评分明显上升,与对照组比较,差异有统计学意义(P<0.05)。结论西黄胶囊可以明显提高乳腺癌术后放疗患者的免疫功能水平,改善放疗期间的生存质量。
目的:探討西黃膠囊對乳腺癌術後放療患者免疫功能及生活質量的影響。方法乳腺癌術後患者43例,隨機分治療組(22例)及對照組(21例)。對照組接受單純放療,治療組在對照組基礎上,加用西黃膠囊治療。在治療前及治療後檢測兩組患者血清T細胞亞群水平,併比較治療前後KPS評分。結果治療組治療後的CD3、CD4和CD4/CD8指標較治療前均有提高(P<0.05),與對照組治療後比較,差異有統計學意義(P<0.05);治療組治療後KPS評分明顯上升,與對照組比較,差異有統計學意義(P<0.05)。結論西黃膠囊可以明顯提高乳腺癌術後放療患者的免疫功能水平,改善放療期間的生存質量。
목적:탐토서황효낭대유선암술후방료환자면역공능급생활질량적영향。방법유선암술후환자43례,수궤분치료조(22례)급대조조(21례)。대조조접수단순방료,치료조재대조조기출상,가용서황효낭치료。재치료전급치료후검측량조환자혈청T세포아군수평,병비교치료전후KPS평분。결과치료조치료후적CD3、CD4화CD4/CD8지표교치료전균유제고(P<0.05),여대조조치료후비교,차이유통계학의의(P<0.05);치료조치료후KPS평분명현상승,여대조조비교,차이유통계학의의(P<0.05)。결론서황효낭가이명현제고유선암술후방료환자적면역공능수평,개선방료기간적생존질량。
Objective To study the clinical effect of Xihuang capsules on immune function of patients with breast cancer receiving postoperative radiotherapy.MethodsDivided 43 patients with breast cancer into two groups: treatment group(n=22) was treated with Xihuang capsules and radiotherapy; control group(n=21) was treated with radiotherapy only. Then T-lymphocyte subsets Resultsand Karnofsky(KPS) scores were compared before and after treatment in the two groups.ResultsThe level of CD3, CD4 and CD4/CD8 in treatment group were improved significantly than those in control group(P<0.05) ; the KPS scores increased more significantly in the treatment group than those in control group (P<0.05).ConclusionXihuang capsules can improve the immune function and life quality of patients with breast caner receiving postoperative radiotherapy.